Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.
Yamamoto Y, Fabbri C, Okuhara D, Takagi R, Kawabata Y, Katayama T, Iyori M, Hasyim AA, Sakamoto A, Mizukami H, Shida H, Lopes S, Yoshida S. Yamamoto Y, et al. Among authors: hasyim aa. Front Immunol. 2024 Apr 30;15:1372584. doi: 10.3389/fimmu.2024.1372584. eCollection 2024. Front Immunol. 2024. PMID: 38745665 Free PMC article.
Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort.
Nurisyah S, Iyori M, Hasyim AA, Sakamoto A, Hashimoto H, Yamagata K, Yamauchi S, Amru K, Zainal KH, Idris I, Yoshida S, Djaharuddin I, Syafruddin D, Bukhari A, Asih PBS, Yusuf Y. Nurisyah S, et al. Among authors: hasyim aa. Antibodies (Basel). 2023 Sep 21;12(3):60. doi: 10.3390/antib12030060. Antibodies (Basel). 2023. PMID: 37753974 Free PMC article.
Sterile protection and transmission blockade by a multistage anti-malarial vaccine in the pre-clinical study.
Iyori M, Blagborough AM, Mizuno T, Abe YI, Nagaoka M, Hori N, Yamagoshi I, Da DF, Gregory WF, Hasyim AA, Yamamoto Y, Sakamoto A, Yoshida K, Mizukami H, Shida H, Yoshida S. Iyori M, et al. Among authors: hasyim aa. Front Immunol. 2022 Sep 29;13:1005476. doi: 10.3389/fimmu.2022.1005476. eCollection 2022. Front Immunol. 2022. PMID: 36248835 Free PMC article.
A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine.
Sakamoto A, Osawa H, Hashimoto H, Mizuno T, Hasyim AA, Abe YI, Okahashi Y, Ogawa R, Iyori M, Shida H, Yoshida S. Sakamoto A, et al. Among authors: hasyim aa. Emerg Microbes Infect. 2022 Dec;11(1):2359-2370. doi: 10.1080/22221751.2022.2122580. Emerg Microbes Infect. 2022. PMID: 36069348 Free PMC article.